Chimerix, Inc. (CMRX) Financials

CMRX Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 194.0 million 19.9 million
2023-12-31 212.8 million 19.7 million
2023-09-30 225.3 million 17.0 million
2023-06-30 241.1 million 17.0 million

CMRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -17.7 million 2.7 million
2023-12-31 -42.6 million 2.3 million
2023-09-30 -17.9 million 7.9 million
2023-06-30 -14.4 million 3.0 million

CMRX Net Income

No data available :(

CMRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 159.0 million - 1.0 million
2023-12-31 182.8 million - 1.2 million
2023-09-30 194.5 million - 1.3 million
2023-06-30 205.8 million - 1.5 million

CMRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 89.3 million
2023-12-31 88.9 million
2023-09-30 88.6 million
2023-06-30 88.6 million

CMRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 27000 18.8 million 5.5 million 3000
2023-12-31 28.1 million 15.6 million 5.2 million -
2023-09-30 15000 17.4 million 9.3 million -
2023-06-30 12000 16.9 million 4.4 million -

CMRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 - -3000
2023-12-31 4000 21.3 million
2023-09-30 11000 15.7 million
2023-06-30 26000 16.9 million

CMRX

Price: $0.99

52 week price:
0.88
1.57

Earnings Per Share: -0.93 USD

P/E Ratio: -0.97

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 701000

Ebitda: -17.6 million

Market Capitalization: 89.6 million

Links: